Image

The Test-to-PrEP Study

The Test-to-PrEP Study

Recruiting
18 years and older
All
Phase N/A
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

To compare the effectiveness of two social network strategies (direct distribution and referral-based distribution) in increasing HIV self-testing (HIVST) completion rates among social network contacts of current Pre-Exposure Prophylaxis (PrEP) clients.

Eligibility

Inclusion Criteria - PrEP Clients (Egos):

  • Stated willingness to provide informed consent.
  • Stated willingness to comply with all study procedures.
  • Stated availability for the duration of the study.
  • Ability to identify members of their social network who may benefit from receiving an HIVST kit and PrEP information.
  • Currently prescribed PrEP by RAPID clinics, including those initiating PrEP on the same day as study enrollment.

Inclusion Criteria for Peers (Alters):

  • Provision of electronic informed consent prior to completion of the Quick Response (QR)-linked survey instruments.

Exclusion Criteria for PrEP Clients (Egos):

  • Inability or refusal to provide informed consent (e.g., cognitive impairment).
  • Unable or unwilling to comply with study procedures per study investigator
  • Inability to identify members of their social network who may benefit from receiving an HIVST kit and PrEP information.
  • Aged 17 years or younger.

Exclusion Criteria for Peers (Alters):

  • Failure to provide electronic informed consent prior to starting QR-linked Alter survey tools.
  • Age 17 years or younger.

Study details
    HIV Infections

NCT06927856

University of Miami

15 October 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.